Where to Inject NAD+: Route, Sites and Safety Questions
Understand subcutaneous versus intramuscular NAD+ prescriptions, site rotation and when to contact your clinician. No universal injection protocol.
Updated
5 min read · 2 sources
On this page
The correct place to inject NAD+ depends on the route your prescriber ordered and the instructions for your specific prescription. For a subcutaneous prescription, clinicians may teach sites such as the abdomen or thigh. An intramuscular prescription needs different site selection and training. Do not switch between routes because an online guide uses a different one 1.
Before administration, confirm the preparation and its handling instructions. Our NAD+ storage and reconstitution guide covers pharmacy labels, warm deliveries and beyond-use dates.
Featured partner
CoreAge Rx
From $93/mo
Check availabilityRead our reviewAffiliate link. We may earn a commission at no extra cost to you.
Affiliate partner
RxSpan MD
Physician-led NAD+ & longevity telehealth
See RxSpan MDThis page helps you check the plan with your clinician. It does not provide a needle-placement demonstration, dose conversion or reconstitution recipe.
Confirm the route before choosing a site
Subcutaneous means the medicine goes into fatty tissue under the skin. Intramuscular means it goes into muscle. An IV delivers medicine through a vein and requires a clinical setting and appropriately qualified staff. Those routes are not interchangeable simply because the bottle says NAD+.
MedlinePlus explains general subcutaneous administration and the need for the right supplies and instruction 1. That guidance is not an NAD+-specific protocol. Your pharmacy label and prescriber's teaching should agree on the route, amount and schedule. If they disagree, resolve it before using the medicine.
Before the first injection
- Confirm the prescribed route.
- Have a clinician identify appropriate sites and teach rotation.
- Resolve any mismatch between the label, supplies and instructions.
- Use the pharmacy’s instructions for that specific preparation.
Abdomen, thigh or arm: is one better?
A suitable site is one your clinician has identified for your route, body and ability to reach it safely. MedlinePlus lists common subcutaneous areas and advises choosing healthy tissue 1. A site used for another medicine or a vaccine is not automatically appropriate for your prescription.
There is no established NAD+-specific evidence showing that moving from the abdomen to the thigh improves energy, reduces aging or produces a better therapeutic response. A claim about a “best NAD+ injection spot” should identify an actual comparison in people, not just a diagram.
Why site rotation matters
Ask the person teaching you to show how to rotate within the approved areas and avoid damaged or irritated tissue. Do not repeatedly use a sore spot to keep to a schedule. General injection guidance advises avoiding redness, swelling, bruising, scarring and other skin damage 1.
Keep the rotation plan simple enough to follow, and report persistent irritation rather than repeatedly changing technique yourself. The side-effects guide distinguishes local discomfort from more serious concerns.
The vial, syringe and instructions must match
Before the first injection, ask your pharmacist to review the actual label and supplies with you. A syringe marking is a volume, not an NAD+ dose. A different vial concentration can change the amount of medicine in the same volume. Do not borrow a conversion from a forum, another prescription or an old vial.
Storage and beyond-use instructions are specific to the preparation. If the product arrives warm, damaged, discolored or with unclear instructions, contact the dispensing pharmacy before use. For context on quality oversight, see NAD+ injection approval status.
When to stop and seek advice
Contact your clinician for a persistent or worsening injection-site problem, suspected infection or a possible dosing mistake. Severe symptoms such as trouble breathing, fainting or chest pain need emergency assessment. Do not try another injection to check whether the reaction repeats.
Compounded products bring quality questions in addition to technique questions 2. An IV clinic checklist is useful if you are considering infusions instead; home shots should not be treated as a do-it-yourself substitute for an IV.
What to ask at your first teaching visit
Have the clinician show the permitted sites on you, demonstrate the supplies and confirm how you will dispose of sharps. Ask how to get help outside office hours and what to do if you miss a scheduled dose. Request written instructions you can keep alongside the label.
Our dosage overview describes the evidence landscape, while NAD+ injection evidence addresses whether the route delivers the benefits advertised. Neither establishes a personal regimen.
What useful first-dose training should accomplish
After training, you should be able to explain the route on your own label, identify the areas the clinician approved and describe who to call if something is unclear. Ask the clinician or pharmacist to watch you explain the plan back. This is particularly helpful if the instructions use both milligrams and syringe markings.
If you cannot comfortably see or reach a suggested area, say so rather than improvising. Dexterity, vision, needle anxiety and the availability of help are practical parts of choosing a plan. A route that looks convenient on a checkout page may be a poor fit without dependable teaching and support.
The important standard is not whether an internet demonstration looks simple. It is whether you understand the plan for the exact product you were dispensed and have a way to get clarification before using it.
No site choice can establish that NAD+ works
Technique and effectiveness answer different questions. Choosing an appropriate site can be part of following a prescription safely, but it cannot supply missing evidence for the product's advertised benefit. A claim about “better absorption” needs to specify what was measured and whether the change affected a meaningful outcome.
For example, a seller may cite oral NR research while discussing an NAD+ shot. Even flawless technique would not make those interventions equivalent. That is why this guide links to the injection evidence separately from administration questions.
How to handle a change in supplies or formulation
If a refill arrives with a different concentration, syringe type or set of directions, ask the pharmacy to reconcile it with the current prescription. Do not assume a familiar-looking vial means the old markings still apply. If the prescriber changes the route, request new route-specific teaching instead of adapting a previous technique.
Keep a photo or copy of the label and the written plan available when calling. Describe the product name, pharmacy and issue clearly. If a possible reaction is the reason for the call, explain when it happened relative to the injection and whether it is worsening. These details help the treating team assess the situation; they do not replace medical advice about what to do next.
Frequently asked questions
Can NAD+ be injected into the stomach?
For some subcutaneous prescriptions, the abdomen is an area a clinician may teach. Follow the route and site instructions for your own prescription rather than choosing a site from a generic guide.
Is the thigh better than the abdomen?
There is no established NAD+-specific comparative evidence showing a superior health benefit from one of these sites. Site selection should follow your prescriber’s teaching.
Can I change an intramuscular prescription to subcutaneous?
Do not change the route yourself. Contact the prescriber and pharmacist for clarification.
References
- MedlinePlus (2025). Subcutaneous (SQ) injections. U.S. National Library of Medicine. https://medlineplus.gov/ency/patientinstructions/000430.htm
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Related reading
NMN Side Effects: What the Human Studies Actually Show
NMN studies offer short-term tolerability data, not proof of long-term safety. Understand the study limits, product quality and questions for your clinician.
ReadAre NAD+ Injections FDA-Approved? What Compounding Means
Compounded NAD+ injections are not FDA-approved. Understand pharmacy oversight, ingredient quality and the questions to ask before paying.
ReadNAD+ With Semaglutide or Tirzepatide: What Is Known
NAD+ is sold alongside GLP-1 medicines, but added benefit is unproven. Understand separate prescriptions, mixed formulations and what to ask.
ReadNAD+ Dosage Guide: How Much Per Day, by Form and Route
What the human trials actually used for NR, NMN, niacin and nicotinamide — plus why the tidy injection and IV dosage charts online have no trial behind them.
ReadTru Niagen Side Effects: What the Trials Report
Tru Niagen's ingredient has a dedicated safety trial — rare for a supplement. What NR trials report at real doses, the flush question, and where the data ends.
ReadNAD+ Therapy for Energy, Focus & Longevity: The Evidence
An honest, citation-backed look at what NAD+ therapy can and cannot do for energy, focus, and longevity — and where the evidence runs out.
Read